RD
Richard J Daly
President and CEODirector

Richard J Daly insider trades: Catalyst Pharmaceuticals (CPRX) stock buys and sales

President and CEO, Catalyst Pharmaceuticals Last trade Aug 26, 2025 49 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2016
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 26, 2025CPRX↓ Sell$474K
May 30, 2025CPRX↓ Sell$1.7M
Jun 4, 2024CPRX↓ Sell$277K
Sep 12, 2019OPNT↑ Buy$25K
May 17, 2017CUR↑ Buy$30K
Feb 24, 2017CUR↑ Buy$10K
Jan 25, 2017CUR↑ Buy$10K
Dec 23, 2016CUR↑ Buy$10K
Nov 25, 2016CUR↑ Buy$10K
Oct 25, 2016CUR↑ Buy$10K
Sep 23, 2016CUR↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CPRX insiders

Open-market trades in the last 12 months

About Richard J Daly's insider trades

Richard J Daly is President and CEO at Catalyst Pharmaceuticals (CPRX). Since Sep 23, 2016, Richard has reported 8 open-market purchases worth $115K and 3 sales worth $2.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (23 filings), option exercises (17 filings), shares withheld for taxes (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CPRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.